Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update
Lay Summary This article discusses the rationale for and the current data on the efficacy and safety of combined advanced targeted therapy (CATT) for the treatment of moderate-to-severe inflammatory bowel disease.
Authors
- Nicole Cornet (ORCID: https://orcid.org/0000-0002-2057-5202)
- Waseem Ahmed (ORCID: https://orcid.org/0000-0002-5587-7964)
- Aiya Aboubakr (ORCID: https://orcid.org/0000-0003-1012-1140)
- Robert Battat (ORCID: https://orcid.org/0000-0002-7421-9764)
Institutions
- Cornell University (US)
- Presbyterian Hospital (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Crohn's and Colitis UK (GB)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1093/ibd/izae189
- Citations
- 6
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.30